Skip to content

Dr. Deborah Fuller explores the Novavax shot on the KNX In Depth Podcast

A fourth COVID vaccine could become available soon here in the U.S.  An FDA advisory panel has just voted to approve the Novavax vaccine. The FDA and the CDC would both need to sign off on it though before shots get into arms.

This works differently than the two mRNA vaccines and the Johnson and Johnson vaccine. But how effective is it at stopping COVID? Deborah Fuller is a vaccine developer and microbiologist at the University of Washington. She runs her own vaccine lab at the school and serves as Associate Director for Research at the Washington National Primate Research Center.